FDA Inspection 1192062 — Avara Liscate Pharmaceutical Services SPA

Avara Liscate Pharmaceutical Services SPA — FEI 3004640070

The FDA completed an inspection of Avara Liscate Pharmaceutical Services SPA on Dec 6, 2022 in Liscate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 6, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liscate (Italy)

Citations

IDCFRDescription
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
354721 CFR 211.46(b)Equipment for Environmental Control
440221 CFR 211.192Written record of investigation incomplete

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.